SREBF1 and cancer: Based on these molecular mechanism findings, we screened drugs targeting FASN and SREBF1 from the Cancer Therapeutics Response Portal (CTRP), Genomics of Drug Sensitivity in Cancer (GDSC), and CellMiner databases.